Acerus Pharmaceuticals Short Interest Ratio and Short Volume

Acerus Pharmaceuticals (OTCMKTS:ASPCF) Short Interest Frequently Asked Questions

What is Acerus Pharmaceuticals' current short interest?

Short interest is the volume of Acerus Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of September 30th, traders have sold 90,000 shares of ASPCF short. Learn More on Acerus Pharmaceuticals' current short interest.

What is a good short interest ratio for Acerus Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. Acerus Pharmaceuticals currently has a short interest ratio of 5.0. Learn More on a good short interest ratio for Acerus Pharmaceuticals

Is Acerus Pharmaceuticals' short interest increasing or decreasing?

Acerus Pharmaceuticals saw a increase in short interest in September. As of September 30th, there was short interest totaling 90,000 shares, an increase of 718.2% from the previous total of 11,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Acerus Pharmaceuticals' short interest compare to its competitors?

0.00% of Acerus Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Acerus Pharmaceuticals: Zynerba Pharmaceuticals, Inc. (4.70%), Adamis Pharmaceuticals Co. (0.00%), Anebulo Pharmaceuticals, Inc. (0.24%), Enlivex Therapeutics Ltd. (0.00%), Tiziana Life Sciences PLC (0.00%), Gemini Therapeutics, Inc. (9.17%), ObsEva SA (1.80%), Vascular Biogenics Ltd. (4.68%), Aptinyx Inc. (1.95%), and OptiNose, Inc. (9.45%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: S&P Global Inc. ($7.35 billion), Advanced Micro Devices, Inc. ($6.43 billion), Charter Communications, Inc. ($5.68 billion), Wayfair Inc. ($4.48 billion), Uber Technologies, Inc. ($3.77 billion), Canadian Pacific Railway Limited ($3.73 billion), Palo Alto Networks, Inc. ($3.10 billion), Zoom Video Communications, Inc. ($2.87 billion), Match Group, Inc. ($2.83 billion), and DoorDash, Inc. ($2.54 billion). View all of the most shorted stocks.

What does it mean to sell short Acerus Pharmaceuticals stock?

Short selling ASPCF is an investing strategy that aims to generate trading profit from Acerus Pharmaceuticals as its price is falling. To short Acerus Pharmaceuticals stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Acerus Pharmaceuticals will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Acerus Pharmaceuticals?

A short squeeze for Acerus Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ASPCF, which in turn drives the price of the stock up even further.

How often is Acerus Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ASPCF, twice per month. The most recent reporting period available is September, 30 2021.